Hidemasa Kuwabara
Gunma University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hidemasa Kuwabara.
Immunopharmacology and Immunotoxicology | 2006
Yasuo Shimizu; Hidemasa Kuwabara; Akihiro Ono; Seiichi Higuchi; Takeshi Hisada; Kunio Dobashi; Mitsuyoshi Utsugi; Yoshinori Mita; Masatomo Mori
The balance between CD4+ T helper (Th1) lymphocytes producing interferon-γ or Interleukin-4 (Th2) in the lungs may vary among diseases and during the progression of interstitial pneumonia (IP). Both idiopathic pulmonary fibrosis (IPF) and collagen vascular diseases (CVD) are associated with IP, but the clinical course and the response to treatment are different. Since Th1 or Th2 modulating drugs have been proven to alter the lymphocyte balance in vitro, it is important to elucidate the Th1/Th2 profile in patients with active IP. Bronchoalveolar lavage (BAL) was performed in patients who had IPF (n = 12) or CVD (n = 12) with IP, as well as in patients who had bronchoectasis and bronchopneumonia (n = 12). The CVD patients had rheumatoid arthritis (n = 6), Sjogren’s syndrome (n = 2), dermatomyositis (n = 1), progressive systemic sclerosis (n = 2), and CREST syndrome (n = 1) as the underlying diseases. IP activity was evaluated by measuring serum KL-6, which is a clinically useful indicator for IP. The Th1/ Th2 balance and the CD4+/CD8+ ratio were determined for lymphocytes obtained from BAL by flow cytometric analysis. In IPF patients, the CD4+/CD8+ ratio was lower than in CVD patients. IPF patients showed Th2 dominance and CVD patients showed Th1 dominance when IP was active as evaluated by the serum KL-6 level. These data indicated that the Th1/Th2 balance of CD4+ T cells in the BAL differs between active IPF and CVD, even though KL-6 is elevated in both diseases. Therefore, the Th1/Th2 profile should be investigated to determine the use of Th1/Th2 modulator therapy for active IP with elevation of KL-6.
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine | 1989
Takada M; Hidemasa Kuwabara; Hitomi Takahashi; Masahiro Uehara; Masuda J; Goto K; Jinbou S; Sekihara T; Toshikazu Nemoto; Setsuo Kobayashi
遠位尿細管アシドーシス(distal renal tubular asidosis, dRTA)による低カリウム血症のため,呼吸筋麻痺が生じてCO2ナルコーシスに陥った症例. CO2ナルコーシスにまで陥る尿細管アシドーシスは極めてまれであり,加えて多彩な自己免疫異常を認めた.橋本病および, Sjogren症候群を合併しており,抗dsDNA抗体も陽性であった.遠位尿細管アシドーシスの発症に免疫学的機序の関与を示唆する症例であり,自己免疫疾患の形質発現を考える上でも貴重な症例と考えられた.
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine | 1987
Hidemasa Kuwabara; Susumu Miura; Hitomi Takahashi; Makoto Takada; Masahiro Uehara; Shozo Saito; Masahide Kurihara; Toshikazu Nemoto; Setsuo Kobayashi
肺癌患者の治療中に,合成抗菌剤により発作性ヘモグロビン尿症を生じたと思われた1例を経験した.本症例は3回にわたって著明なヘモグロビン尿が出現したが,合成抗菌剤の中止により消失した.クームス試験,手足冷却試験, Donath-Landsteiner抗体,さらにHam test, sugar water test等すべて陰性であった.本症例の溶血は何らかの赤血球膜の脆弱性亢進が薬物により生じた結果発症したものと考えられた.
Internal Medicine | 1995
Takeshi Hisada; Hidemasa Kuwabara; Takeshi Tsunoda; Kaori Kaneko; Shouzou Kubota; Yoshihiro Miwa; Masatomo Mori
The Journal of Nuclear Medicine | 1998
Osamu Mitomo; Sakae Aoki; Takeshi Tsunoda; Masafumi Yamaguchi; Hidemasa Kuwabara
Internal Medicine | 2002
Akihiro Ono; Kumiko Nakamura; Seiichi Higuchi; Yoshihiro Miwa; Kazumi Nakamura; Takeshi Tsunoda; Hidemasa Kuwabara; Yumiko Furuya; Kunio Dobashi; Masatomo Mori
The Kitakanto Medical Journal | 2008
Mari Kato; Takeshi Hisada; Tamotsu Ishizuka; Haruka Aoki; Noriko Yanagitani; Kyoichi Kaira; Mitsuyoshi Utsugi; Yasuo Shimizu; Noriaki Sunaga; Kunio Dobashi; Masatomo Mori; Hidemasa Kuwabara
Nihon Kikan Shokudoka Gakkai Kaiho | 1980
Hidemasa Kuwabara
Rinsho Yakuri\/japanese Journal of Clinical Pharmacology and Therapeutics | 1985
Nobumichi Morishita; Yoshiro Tomono; Jiro Hasegawa; Toshikazu Nemoto; Hidemasa Kuwabara; Satoshi Tsuchiya; Setsuo Kobayashi
The Kitakanto Medical Journal | 2015
Hidemasa Kuwabara; Noriko Yamaoka; Junko Oomaki; Mitsuo Suzuki